A ubiquitin-proteasome system-related signature to predict prognosis, immune infiltration, and therapy efficacy for breast cancer.

MLA

Liu, Xiao, et al. “A Ubiquitin-Proteasome System-Related Signature to Predict Prognosis, Immune Infiltration, and Therapy Efficacy for Breast Cancer.” Immunologic Research, vol. 72, no. 3, June 2024, pp. 368–82. EBSCOhost, https://doi.org/10.1007/s12026-023-09440-x.

APA

Liu, X., Wang, M., Wang, Q., & Zhang, H. (2024). A ubiquitin-proteasome system-related signature to predict prognosis, immune infiltration, and therapy efficacy for breast cancer. Immunologic Research, 72(3), 368–382. https://doi.org/10.1007/s12026-023-09440-x

Chicago

Liu, Xiao, Meihuan Wang, Qian Wang, and Huawei Zhang. 2024. “A Ubiquitin-Proteasome System-Related Signature to Predict Prognosis, Immune Infiltration, and Therapy Efficacy for Breast Cancer.” Immunologic Research 72 (3): 368–82. doi:10.1007/s12026-023-09440-x.